Advertisement
Home Tags Cancer: Throat

Tag: Cancer: Throat

The learning curve for transoral robotic surgery for squamous cell carcinoma of the oropharynx is surgeon-specific

Surgeon-Specific Learning Curve for Transoral Robotic Surgery

0
Findings for oncologic surgeons performing TORS for squamous cell carcinoma of the oropharynx
Twenty-three percent of patients with head and neck squamous cell carcinoma have cardiovascular disease at diagnosis

High CVD Risk in Patients With Head, Neck Squamous Cell Cancer

0
Twenty-three and 24 percent of patients had CVD and uncontrolled blood pressure at diagnosis
Patients with sustained or newly developed cancer cachexia at six and 12 months after initial treatment for advanced head and neck squamous cell carcinoma are at higher risk of cancer recurrences

Cancer Cachexia Associated With Poor Outcomes

0
Findings at six and 12 months after treatment for advanced head and neck cancer
There is a direct correlation between the pretreatment serum uric acid level and tumor progression in patients with locally advanced nasopharyngeal carcinoma

Uric Acid May Mark Progression for Nasopharyngeal Cancer

0
High pretreatment uric acid may be clinical biomarker for lung metastasis
For patients with head and neck cancer receiving radiotherapy

Radiation Dose to Head & Neck Tied to Thyroid Dysfunction Risk

0
Findings in patients with head and neck cancer receiving RT; female sex, concurrent chemo up risk
For nonmetastatic nasopharyngeal carcinoma

Adjuvant Chemo Plus CRT Best in Nasopharyngeal Carcinoma

0
Highest survival benefit for addition of AC to CRT, with consistent improvement for all end points
For patients with squamous cell carcinoma

Microsurgical Head and Neck Reconstruction Is Cost-Effective

0
Cost-effective versus locoregional flaps for all stages of SCC, especially in early-stage cancer
A stepped care program is likely to be cost-effective for patients with head and neck cancer or lung cancer who have psychological distress

Stepped Care Likely to Be Cost-Effective in Head & Neck, Lung CA

0
Mean costs lower and mean number of quality-adjusted life-years higher in intervention group
Patients with multiple areas of dysplastic squamous epithelium have increased risk for metachronous squamous cell carcinomas in the upper aerodigestive tract

Multiple Dysplastic Lesions in Esophagus Up Risk of SCC

0
Increased risk of multiple squamous cell carcinomas in esophagus and head and neck
Nivolumab is associated with longer overall survival than standard single-agent therapy in patients with platinum-refractory

Nivolumab Ups Overall Survival in Head, Neck Cancer

0
Longer overall survival compared with single-agent therapy for platinum-refractory squamous-cell cancer